Buy Cipla, target price Rs 685: Elara Capital

-
Cipla’s recent inhaler approval of generic of Proventil from the USFDA would aid in strong earnings visibility in the near term.

from Stocks-Markets-Economic Times https://ift.tt/2xaxGWg

Comments

Post a Comment

Popular posts from this blog

Gokaldas Exports reports 152% jump in revenues

-
Image
The company reported a profit before tax (PBT) of Rs 50.8 crore compared to a loss of Rs.2.6 crore in the same period last year and a PBT Rs 52.4 crore in the Jan-March quarter of the last fiscal year. In the first quarter of this fiscal year, the company considered a share-based compensation charge of Rs 6 crore, excluding which the profit before tax was Rs 56.8 crore. from Stocks-Markets-Economic Times https://ift.tt/biomg7W
Read more

Sebi mulls relaxation in timelines for FPIs' material change disclosures

-
In its consultation paper, Sebi proposed categorising material changes notified by FPIs into two groups to set timelines for reporting such changes. Type I includes changes that require FPIs to seek fresh registration, or which affect any privileges or exemption available to such foreign investors and Type II includes all other material changes. from Stocks-Markets-Economic Times https://ift.tt/aRgHPVe
Read more